COMPANY

Lundbeck

Profile checked Oct 10, 2026

Keywords: Epilepsy Infantile Spasms Generalized Epilepsy Seizures Lennox-Gastaut Syndrome Adult Refractory Complex Partial Seizures Parkinson's Disease Psychotic Disorders Clobazam Sabril® Sabril Vigabatrin

9Trials (company is sponsor)

Timeline

2012-06 Trial start Phase 4: An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms source ↗
2010-12 Trial start Phase 4: A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®) source ↗
2010-06 Trial start Phase 3: Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy source ↗
2009-08 Trial start —: Sabril Patient Registry source ↗
2007-08 Trial start Phase 3: Clobazam in Patients With Lennox-Gastaut Syndrome source ↗
2007-04 Trial start Phase 1: A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy source ↗
2005-12 Trial start Phase 3: Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome source ↗
2005-10 Trial start Phase 2: Clobazam in Subjects With Lennox-Gastaut Syndrome source ↗
2005-07 Trial start Phase 2: Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease source ↗

Clinical trials (lead sponsor) 9

Record	Title	Phase	Status	Start	Primary completion
NCT01160770	Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome	Phase 3	Completed	2005-12	2012-02 (actual)
NCT01128959	Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy	Phase 3	Completed	2010-06	2013-01 (actual)
NCT01073579	Sabril Patient Registry	Not listed	Completed	2009-08	2016-07 (actual)
NCT01278173	A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)	Phase 4	Completed	2010-12	2015-05 (actual)
NCT01413711	An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms	Phase 4	Withdrawn	2012-06	2013-09 (estimated)
NCT00518713	Clobazam in Patients With Lennox-Gastaut Syndrome	Phase 3	Completed	2007-08	2009-12 (actual)
NCT00162981	Clobazam in Subjects With Lennox-Gastaut Syndrome	Phase 2	Completed	2005-10	2006-08 (actual)
NCT00125138	Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease	Phase 2	Completed	2005-07	2008-03 (actual)
NCT01079351	A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy	Phase 1	Completed	2007-04	2009-03 (actual)